It has been approved by the China's NMPA for: 1) the treatment of adult patients with locally advanced or metastatic EGFR T790M-mutated non-small cell lung cancer (NSCLC), who have previously ...

Promega MSI technology is now available in a diagnostic test in China National Medical Products Administration (NMPA) awarded a medical device registration certificate to Promega ProDx MSI ...

Simcere Zaiming Pharmaceutical Co. Ltd. has received clinical trial approval from China’s National Medical Products Administration (NMPA) for the company’s antibody-drug conjugate (ADC), SIM-0686, for ...

of the China National Medical Products Administration (NMPA), which accepted the New Drug Application (NDA) of zurletrectinib for the treatment of patients with advanced solid tumors harboring ...

(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy ...

of the National Medical Products Administration (NMPA), and is currently undergoing phase I/II clinical trials in China for the treatment of solid tumours. This milestone marks another breakthrough in ...